These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7675313)

  • 1. Circadian responses to light: the calmodulin connection.
    Golombek DA; Ralph MR
    Neurosci Lett; 1995 Jun; 192(2):101-4. PubMed ID: 7675313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KN-62, an inhibitor of Ca2+/calmodulin kinase II, attenuates circadian responses to light.
    Golombek DA; Ralph MR
    Neuroreport; 1994 Aug; 5(13):1638-40. PubMed ID: 7819537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal, circadian and photic regulation of calcium/calmodulin-dependent kinase II and neuronal nitric oxide synthase in the hamster suprachiasmatic nuclei.
    Agostino PV; Ferreyra GA; Murad AD; Watanabe Y; Golombek DA
    Neurochem Int; 2004 Jun; 44(8):617-25. PubMed ID: 15016477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of calcium-calmodulin protein kinase but not mitogen-activated protein kinase in light-induced phase delays and Per gene expression in the suprachiasmatic nucleus of the hamster.
    Yokota S; Yamamoto M; Moriya T; Akiyama M; Fukunaga K; Miyamoto E; Shibata S
    J Neurochem; 2001 Apr; 77(2):618-27. PubMed ID: 11299324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-photic circadian entrainment in the Syrian hamster is not associated with phosphorylation of the transcriptional regulator CREB within the suprachiasmatic nucleus, but is associated with adrenocortical activation.
    Sumova A; Ebling FJ; Maywood ES; Herbert J; Hastings MH
    Neuroendocrinology; 1994 Jun; 59(6):579-89. PubMed ID: 8084382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic signalling in the rodent neonatal suprachiasmatic nucleus identifies a role for protein kinase A and mitogen-activated protein kinase in circadian entrainment.
    Schurov IL; Hepworth TJ; Hastings MH
    Eur J Neurosci; 2002 Jan; 15(2):223-32. PubMed ID: 11849290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of calmodulin and Ca2+/calmodulin-dependent protein kinase II in the circadian rhythms controlled by the suprachiasmatic nucleus.
    Fukushima T; Shimazoe T; Shibata S; Watanabe A; Ono M; Hamada T; Watanabe S
    Neurosci Lett; 1997 May; 227(1):45-8. PubMed ID: 9178855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
    Tokumitsu H; Chijiwa T; Hagiwara M; Mizutani A; Terasawa M; Hidaka H
    J Biol Chem; 1990 Mar; 265(8):4315-20. PubMed ID: 2155222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling pathways for antigen receptor-mediated induction of transcription factor CREB in B lymphocytes.
    Xie H; Wang Z; Rothstein TL
    Cell Immunol; 1996 May; 169(2):264-70. PubMed ID: 8620554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiotensin II- and potassium-mediated aldosterone secretion by KN-62 suggests involvement of Ca(2+)-calmodulin dependent protein kinase II in aldosterone secretion.
    Ganguly A; Li L; Haxton M
    Biochem Biophys Res Commun; 1995 Apr; 209(3):916-20. PubMed ID: 7733984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimuli which entrain the circadian clock of the neonatal Syrian hamster in vivo regulate the phosphorylation of the transcription factor CREB in the suprachiasmatic nucleus in vitro.
    McNulty S; Schurov IL; Sloper PJ; Hastings MH
    Eur J Neurosci; 1998 Mar; 10(3):1063-72. PubMed ID: 9753174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma.
    Williams CL; Phelps SH; Porter RA
    Biochem Pharmacol; 1996 Mar; 51(5):707-15. PubMed ID: 8615909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calmodulin inhibitors on amylase secretion from rat pancreatic acini.
    Ishiguro H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Sobajima H; Nakae Y; Tanikawa M; Hidaka H
    Digestion; 1992; 53(3-4):162-70. PubMed ID: 1283979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca2+/calmodulin-dependent protein kinase II-dependent long-term potentiation in the rat suprachiasmatic nucleus and its inhibition by melatonin.
    Fukunaga K; Horikawa K; Shibata S; Takeuchi Y; Miyamoto E
    J Neurosci Res; 2002 Dec; 70(6):799-807. PubMed ID: 12444602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a 80 kDa calmodulin-binding protein as a new Ca2+/calmodulin-dependent kinase by renaturation blotting assay (RBA).
    Kato M; Hagiwara M; Hidaka H
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):339-42. PubMed ID: 1310591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a new Ca2(+)-calmodulin-dependent protein kinase II inhibitor on GABA release in cerebrospinal fluid of the rat.
    Ishikawa N; Hashiba Y; Hidaka H
    J Pharmacol Exp Ther; 1990 Aug; 254(2):598-602. PubMed ID: 2384887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KN-62, a specific Ca++/calmodulin-dependent protein kinase inhibitor, reversibly depresses the rate of beating of cultured fetal mouse cardiac myocytes.
    Okazaki K; Ishikawa T; Inui M; Tada M; Goshima K; Okamoto T; Hidaka H
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1319-24. PubMed ID: 7932185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calmodulin dependent regulation of smooth muscle contraction].
    Hidaka H; Ishikawa T; Tokumitsu H
    Nihon Heikatsukin Gakkai Zasshi; 1990 Oct; 26(5):234-5. PubMed ID: 2103931
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of agonist-mediated calcium entry by calmodulin antagonists and by the Ca2+/calmodulin kinase II inhibitor KN-62. Studies with thyroid FRTL-5 cells.
    Törnquist K; Ekokoski E
    J Endocrinol; 1996 Jan; 148(1):131-8. PubMed ID: 8568460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular pharmacology of a calcium/calmodulin-dependent protein kinase II (CaM kinase II) inhibitor, KN-62, and proposal of CaM kinase phosphorylation cascades.
    Hidaka H; Yokokura H
    Adv Pharmacol; 1996; 36():193-219. PubMed ID: 8783561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.